NovoCure Stock: Buy Rating As Pipeline Gains Drive Renewed Momentum (NASDAQ:NVCR)

Core Insights - NovoCure Limited (NASDAQ: NVCR) is experiencing a notable month with double-digit stock gains, although it remains close to its 52-week lows [1] Financial Performance - The company is set to release its Q3 financial results, which will provide further insights into its performance and market position [1]